WO2023161827 - ANTIMICROBIAL SOLUTIONS COMPRISING TETRASODIUM EDTA, ETHANOL, AND CHLORHEXIDINE AND DISINFECTING WIPES COMPRISING SAID SOLUTIONS

National phase entry:
Publication Number WO/2023/161827
Publication Date 31.08.2023
International Application No. PCT/IB2023/051636
International Filing Date 22.02.2023
Title **
[English] ANTIMICROBIAL SOLUTIONS COMPRISING TETRASODIUM EDTA, ETHANOL, AND CHLORHEXIDINE AND DISINFECTING WIPES COMPRISING SAID SOLUTIONS
[French] SOLUTIONS ANTIMICROBIENNES COMPRENANT DE L'EDTA TÉTRASODIQUE, DE L'ÉTHANOL ET DE LA CHLORHEXIDINE ET LINGETTES DÉSINFECTANTES COMPRENANT LESDITES SOLUTIONS
Applicants **
STERILECARE INC.
Inventors
MUELLER, Karen
Priority Data
63/312,501   22.02.2022   US
63/312,509   22.02.2022   US
63/312,516   22.02.2022   US
63/312,628   22.02.2022   US
63/396,052   08.08.2022   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2502
EPO Filing, Examination, Granting12501
Japan Filing, Examination, Granting2150
South Korea Filing, Examination, Granting2172
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 24,065

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] Provided herein are compositions and solutions containing tetrasodium EDTA, ethanol, and chlorhexidine, and optionally taurolidine, heparin, or a thrombolytic agent. The compositions may be disposed on a cleaning wipe to provide broad-spectrum antimicrobial activity on planktonic and biofilm cells of clinically relevant pathogens. Also provided herein is a peripheral line placement kit containing the compositions and solutions.[French] L'invention concerne des compositions et des solutions contenant de l'EDTA tétrasodique, de l'éthanol et de la chlorhexidine, et éventuellement de la taurolidine, de l'héparine ou un agent thrombolytique. Les compositions peuvent être disposées sur une lingette de nettoyage pour fournir une activité antimicrobienne à large spectre à des cellules planctoniques et de biofilm d'agents pathogènes cliniquement pertinents. L'invention concerne également un kit de placement de ligne périphérique contenant les compositions et les solutions.

Rejoining the server...